COVID-19 Impact on Global Sustained Release Injectables Market Insights, Forecast to 2026
Sustained Release Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Sustained Release Injectables market is segmented into
The Sustained Release Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sustained Release Injectables market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Sustained Release Injectables Market Share Analysis
Sustained Release Injectables market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Sustained Release Injectables by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Sustained Release Injectables business, the date to enter into the Sustained Release Injectables market, Sustained Release Injectables product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Sustained Release Injectables market is segmented into
- Naltrexone
- Exenatide
- Estradiol
- Other
- Diabetes
- Leukemia
- Acromegaly
- Other
The Sustained Release Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sustained Release Injectables market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Sustained Release Injectables Market Share Analysis
Sustained Release Injectables market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Sustained Release Injectables by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Sustained Release Injectables business, the date to enter into the Sustained Release Injectables market, Sustained Release Injectables product introduction, recent developments, etc.
The major vendors covered:
- AstraZeneca
- Eli Lilly
- Sanofi
- Roche
- Novartis
- Aurobindo
- Avadel
- Biomarin
- Camurus
- Critical Pharmaceuticals
- Alkermes
- Amylin
- Ascendis Pharma
1 STUDY COVERAGE
1.1 Sustained Release Injectables Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Sustained Release Injectables Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Sustained Release Injectables Market Size Growth Rate by Type
1.4.2 Naltrexone
1.4.3 Exenatide
1.4.4 Estradiol
1.4.5 Other
1.5 Market by Application
1.5.1 Global Sustained Release Injectables Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Leukemia
1.5.4 Acromegaly
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
1.6.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
1.6.1.1 Sustained Release Injectables Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sustained Release Injectables Market Size Estimates and Forecasts
2.1.1 Global Sustained Release Injectables Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Sustained Release Injectables Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Sustained Release Injectables Production Estimates and Forecasts 2015-2026
2.2 Global Sustained Release Injectables Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Sustained Release Injectables Manufacturers Geographical Distribution
2.4 Key Trends for Sustained Release Injectables Markets & Products
2.5 Primary Interviews with Key Sustained Release Injectables Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity
3.1.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Sustained Release Injectables Manufacturers by Production (2015-2020)
3.1.3 Global Top Sustained Release Injectables Manufacturers Market Share by Production
3.2 Global Top Sustained Release Injectables Manufacturers by Revenue
3.2.1 Global Top Sustained Release Injectables Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Sustained Release Injectables Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2019
3.3 Global Sustained Release Injectables Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 SUSTAINED RELEASE INJECTABLES PRODUCTION BY REGIONS
4.1 Global Sustained Release Injectables Historic Market Facts & Figures by Regions
4.1.1 Global Top Sustained Release Injectables Regions by Production (2015-2020)
4.1.2 Global Top Sustained Release Injectables Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Sustained Release Injectables Production (2015-2020)
4.2.2 North America Sustained Release Injectables Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Sustained Release Injectables Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Sustained Release Injectables Production (2015-2020)
4.3.2 Europe Sustained Release Injectables Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Sustained Release Injectables Import & Export (2015-2020)
4.4 China
4.4.1 China Sustained Release Injectables Production (2015-2020)
4.4.2 China Sustained Release Injectables Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Sustained Release Injectables Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Sustained Release Injectables Production (2015-2020)
4.5.2 Japan Sustained Release Injectables Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Sustained Release Injectables Import & Export (2015-2020)
5 SUSTAINED RELEASE INJECTABLES CONSUMPTION BY REGION
5.1 Global Top Sustained Release Injectables Regions by Consumption
5.1.1 Global Top Sustained Release Injectables Regions by Consumption (2015-2020)
5.1.2 Global Top Sustained Release Injectables Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Sustained Release Injectables Consumption by Application
5.2.2 North America Sustained Release Injectables Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Sustained Release Injectables Consumption by Application
5.3.2 Europe Sustained Release Injectables Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Sustained Release Injectables Consumption by Application
5.4.2 Asia Pacific Sustained Release Injectables Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Sustained Release Injectables Consumption by Application
5.5.2 Central & South America Sustained Release Injectables Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Sustained Release Injectables Consumption by Application
5.6.2 Middle East and Africa Sustained Release Injectables Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Sustained Release Injectables Market Size by Type (2015-2020)
6.1.1 Global Sustained Release Injectables Production by Type (2015-2020)
6.1.2 Global Sustained Release Injectables Revenue by Type (2015-2020)
6.1.3 Sustained Release Injectables Price by Type (2015-2020)
6.2 Global Sustained Release Injectables Market Forecast by Type (2021-2026)
6.2.1 Global Sustained Release Injectables Production Forecast by Type (2021-2026)
6.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2021-2026)
6.2.3 Global Sustained Release Injectables Price Forecast by Type (2021-2026)
6.3 Global Sustained Release Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Sustained Release Injectables Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Sustained Release Injectables Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Corporation Information
8.1.2 AstraZeneca Overview and Its Total Revenue
8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 AstraZeneca Product Description
8.1.5 AstraZeneca Recent Development
8.2 Eli Lilly
8.2.1 Eli Lilly Corporation Information
8.2.2 Eli Lilly Overview and Its Total Revenue
8.2.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Eli Lilly Product Description
8.2.5 Eli Lilly Recent Development
8.3 Sanofi
8.3.1 Sanofi Corporation Information
8.3.2 Sanofi Overview and Its Total Revenue
8.3.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Sanofi Product Description
8.3.5 Sanofi Recent Development
8.4 Roche
8.4.1 Roche Corporation Information
8.4.2 Roche Overview and Its Total Revenue
8.4.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Roche Product Description
8.4.5 Roche Recent Development
8.5 Novartis
8.5.1 Novartis Corporation Information
8.5.2 Novartis Overview and Its Total Revenue
8.5.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Novartis Product Description
8.5.5 Novartis Recent Development
8.6 Aurobindo
8.6.1 Aurobindo Corporation Information
8.6.2 Aurobindo Overview and Its Total Revenue
8.6.3 Aurobindo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Aurobindo Product Description
8.6.5 Aurobindo Recent Development
8.7 Avadel
8.7.1 Avadel Corporation Information
8.7.2 Avadel Overview and Its Total Revenue
8.7.3 Avadel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Avadel Product Description
8.7.5 Avadel Recent Development
8.8 Biomarin
8.8.1 Biomarin Corporation Information
8.8.2 Biomarin Overview and Its Total Revenue
8.8.3 Biomarin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Biomarin Product Description
8.8.5 Biomarin Recent Development
8.9 Camurus
8.9.1 Camurus Corporation Information
8.9.2 Camurus Overview and Its Total Revenue
8.9.3 Camurus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Camurus Product Description
8.9.5 Camurus Recent Development
8.10 Critical Pharmaceuticals
8.10.1 Critical Pharmaceuticals Corporation Information
8.10.2 Critical Pharmaceuticals Overview and Its Total Revenue
8.10.3 Critical Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Critical Pharmaceuticals Product Description
8.10.5 Critical Pharmaceuticals Recent Development
8.11 Alkermes
8.11.1 Alkermes Corporation Information
8.11.2 Alkermes Overview and Its Total Revenue
8.11.3 Alkermes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Alkermes Product Description
8.11.5 Alkermes Recent Development
8.12 Amylin
8.12.1 Amylin Corporation Information
8.12.2 Amylin Overview and Its Total Revenue
8.12.3 Amylin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Amylin Product Description
8.12.5 Amylin Recent Development
8.13 Ascendis Pharma
8.13.1 Ascendis Pharma Corporation Information
8.13.2 Ascendis Pharma Overview and Its Total Revenue
8.13.3 Ascendis Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Ascendis Pharma Product Description
8.13.5 Ascendis Pharma Recent Development
8.14 Taiwan Liposome Company
8.14.1 Taiwan Liposome Company Corporation Information
8.14.2 Taiwan Liposome Company Overview and Its Total Revenue
8.14.3 Taiwan Liposome Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Taiwan Liposome Company Product Description
8.14.5 Taiwan Liposome Company Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Sustained Release Injectables Regions Forecast by Revenue (2021-2026)
9.2 Global Top Sustained Release Injectables Regions Forecast by Production (2021-2026)
9.3 Key Sustained Release Injectables Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 SUSTAINED RELEASE INJECTABLES CONSUMPTION FORECAST BY REGION
10.1 Global Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.2 North America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.3 Europe Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.5 Latin America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Sustained Release Injectables Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Sustained Release Injectables Sales Channels
11.2.2 Sustained Release Injectables Distributors
11.3 Sustained Release Injectables Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL SUSTAINED RELEASE INJECTABLES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Sustained Release Injectables Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Sustained Release Injectables Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Sustained Release Injectables Market Size Growth Rate by Type
1.4.2 Naltrexone
1.4.3 Exenatide
1.4.4 Estradiol
1.4.5 Other
1.5 Market by Application
1.5.1 Global Sustained Release Injectables Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Leukemia
1.5.4 Acromegaly
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
1.6.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
1.6.1.1 Sustained Release Injectables Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sustained Release Injectables Market Size Estimates and Forecasts
2.1.1 Global Sustained Release Injectables Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Sustained Release Injectables Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Sustained Release Injectables Production Estimates and Forecasts 2015-2026
2.2 Global Sustained Release Injectables Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Sustained Release Injectables Manufacturers Geographical Distribution
2.4 Key Trends for Sustained Release Injectables Markets & Products
2.5 Primary Interviews with Key Sustained Release Injectables Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity
3.1.1 Global Top Sustained Release Injectables Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Sustained Release Injectables Manufacturers by Production (2015-2020)
3.1.3 Global Top Sustained Release Injectables Manufacturers Market Share by Production
3.2 Global Top Sustained Release Injectables Manufacturers by Revenue
3.2.1 Global Top Sustained Release Injectables Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Sustained Release Injectables Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2019
3.3 Global Sustained Release Injectables Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 SUSTAINED RELEASE INJECTABLES PRODUCTION BY REGIONS
4.1 Global Sustained Release Injectables Historic Market Facts & Figures by Regions
4.1.1 Global Top Sustained Release Injectables Regions by Production (2015-2020)
4.1.2 Global Top Sustained Release Injectables Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Sustained Release Injectables Production (2015-2020)
4.2.2 North America Sustained Release Injectables Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Sustained Release Injectables Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Sustained Release Injectables Production (2015-2020)
4.3.2 Europe Sustained Release Injectables Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Sustained Release Injectables Import & Export (2015-2020)
4.4 China
4.4.1 China Sustained Release Injectables Production (2015-2020)
4.4.2 China Sustained Release Injectables Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Sustained Release Injectables Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Sustained Release Injectables Production (2015-2020)
4.5.2 Japan Sustained Release Injectables Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Sustained Release Injectables Import & Export (2015-2020)
5 SUSTAINED RELEASE INJECTABLES CONSUMPTION BY REGION
5.1 Global Top Sustained Release Injectables Regions by Consumption
5.1.1 Global Top Sustained Release Injectables Regions by Consumption (2015-2020)
5.1.2 Global Top Sustained Release Injectables Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Sustained Release Injectables Consumption by Application
5.2.2 North America Sustained Release Injectables Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Sustained Release Injectables Consumption by Application
5.3.2 Europe Sustained Release Injectables Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Sustained Release Injectables Consumption by Application
5.4.2 Asia Pacific Sustained Release Injectables Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Sustained Release Injectables Consumption by Application
5.5.2 Central & South America Sustained Release Injectables Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Sustained Release Injectables Consumption by Application
5.6.2 Middle East and Africa Sustained Release Injectables Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Sustained Release Injectables Market Size by Type (2015-2020)
6.1.1 Global Sustained Release Injectables Production by Type (2015-2020)
6.1.2 Global Sustained Release Injectables Revenue by Type (2015-2020)
6.1.3 Sustained Release Injectables Price by Type (2015-2020)
6.2 Global Sustained Release Injectables Market Forecast by Type (2021-2026)
6.2.1 Global Sustained Release Injectables Production Forecast by Type (2021-2026)
6.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2021-2026)
6.2.3 Global Sustained Release Injectables Price Forecast by Type (2021-2026)
6.3 Global Sustained Release Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Sustained Release Injectables Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Sustained Release Injectables Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Corporation Information
8.1.2 AstraZeneca Overview and Its Total Revenue
8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 AstraZeneca Product Description
8.1.5 AstraZeneca Recent Development
8.2 Eli Lilly
8.2.1 Eli Lilly Corporation Information
8.2.2 Eli Lilly Overview and Its Total Revenue
8.2.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Eli Lilly Product Description
8.2.5 Eli Lilly Recent Development
8.3 Sanofi
8.3.1 Sanofi Corporation Information
8.3.2 Sanofi Overview and Its Total Revenue
8.3.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Sanofi Product Description
8.3.5 Sanofi Recent Development
8.4 Roche
8.4.1 Roche Corporation Information
8.4.2 Roche Overview and Its Total Revenue
8.4.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Roche Product Description
8.4.5 Roche Recent Development
8.5 Novartis
8.5.1 Novartis Corporation Information
8.5.2 Novartis Overview and Its Total Revenue
8.5.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Novartis Product Description
8.5.5 Novartis Recent Development
8.6 Aurobindo
8.6.1 Aurobindo Corporation Information
8.6.2 Aurobindo Overview and Its Total Revenue
8.6.3 Aurobindo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Aurobindo Product Description
8.6.5 Aurobindo Recent Development
8.7 Avadel
8.7.1 Avadel Corporation Information
8.7.2 Avadel Overview and Its Total Revenue
8.7.3 Avadel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Avadel Product Description
8.7.5 Avadel Recent Development
8.8 Biomarin
8.8.1 Biomarin Corporation Information
8.8.2 Biomarin Overview and Its Total Revenue
8.8.3 Biomarin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Biomarin Product Description
8.8.5 Biomarin Recent Development
8.9 Camurus
8.9.1 Camurus Corporation Information
8.9.2 Camurus Overview and Its Total Revenue
8.9.3 Camurus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Camurus Product Description
8.9.5 Camurus Recent Development
8.10 Critical Pharmaceuticals
8.10.1 Critical Pharmaceuticals Corporation Information
8.10.2 Critical Pharmaceuticals Overview and Its Total Revenue
8.10.3 Critical Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Critical Pharmaceuticals Product Description
8.10.5 Critical Pharmaceuticals Recent Development
8.11 Alkermes
8.11.1 Alkermes Corporation Information
8.11.2 Alkermes Overview and Its Total Revenue
8.11.3 Alkermes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Alkermes Product Description
8.11.5 Alkermes Recent Development
8.12 Amylin
8.12.1 Amylin Corporation Information
8.12.2 Amylin Overview and Its Total Revenue
8.12.3 Amylin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Amylin Product Description
8.12.5 Amylin Recent Development
8.13 Ascendis Pharma
8.13.1 Ascendis Pharma Corporation Information
8.13.2 Ascendis Pharma Overview and Its Total Revenue
8.13.3 Ascendis Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Ascendis Pharma Product Description
8.13.5 Ascendis Pharma Recent Development
8.14 Taiwan Liposome Company
8.14.1 Taiwan Liposome Company Corporation Information
8.14.2 Taiwan Liposome Company Overview and Its Total Revenue
8.14.3 Taiwan Liposome Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Taiwan Liposome Company Product Description
8.14.5 Taiwan Liposome Company Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Sustained Release Injectables Regions Forecast by Revenue (2021-2026)
9.2 Global Top Sustained Release Injectables Regions Forecast by Production (2021-2026)
9.3 Key Sustained Release Injectables Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 SUSTAINED RELEASE INJECTABLES CONSUMPTION FORECAST BY REGION
10.1 Global Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.2 North America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.3 Europe Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.5 Latin America Sustained Release Injectables Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Sustained Release Injectables Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Sustained Release Injectables Sales Channels
11.2.2 Sustained Release Injectables Distributors
11.3 Sustained Release Injectables Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL SUSTAINED RELEASE INJECTABLES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Sustained Release Injectables Key Market Segments in This Study
Table 2. Ranking of Global Top Sustained Release Injectables Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sustained Release Injectables Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Naltrexone
Table 5. Major Manufacturers of Exenatide
Table 6. Major Manufacturers of Estradiol
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Sustained Release Injectables Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sustained Release Injectables Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
Table 13. Global Sustained Release Injectables Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Sustained Release Injectables Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2019)
Table 17. Sustained Release Injectables Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Sustained Release Injectables Product Offered
Table 19. Date of Manufacturers Enter into Sustained Release Injectables Market
Table 20. Key Trends for Sustained Release Injectables Markets & Products
Table 21. Main Points Interviewed from Key Sustained Release Injectables Players
Table 22. Global Sustained Release Injectables Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Sustained Release Injectables Production Share by Manufacturers (2015-2020)
Table 24. Sustained Release Injectables Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Sustained Release Injectables Revenue Share by Manufacturers (2015-2020)
Table 26. Sustained Release Injectables Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sustained Release Injectables Production by Regions (2015-2020) (K Units)
Table 29. Global Sustained Release Injectables Production Market Share by Regions (2015-2020)
Table 30. Global Sustained Release Injectables Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Sustained Release Injectables Revenue Market Share by Regions (2015-2020)
Table 32. Key Sustained Release Injectables Players in North America
Table 33. Import & Export of Sustained Release Injectables in North America (K Units)
Table 34. Key Sustained Release Injectables Players in Europe
Table 35. Import & Export of Sustained Release Injectables in Europe (K Units)
Table 36. Key Sustained Release Injectables Players in China
Table 37. Import & Export of Sustained Release Injectables in China (K Units)
Table 38. Key Sustained Release Injectables Players in Japan
Table 39. Import & Export of Sustained Release Injectables in Japan (K Units)
Table 40. Global Sustained Release Injectables Consumption by Regions (2015-2020) (K Units)
Table 41. Global Sustained Release Injectables Consumption Market Share by Regions (2015-2020)
Table 42. North America Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 43. North America Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 45. Europe Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Sustained Release Injectables Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Sustained Release Injectables Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 53. Global Sustained Release Injectables Production by Type (2015-2020) (K Units)
Table 54. Global Sustained Release Injectables Production Share by Type (2015-2020)
Table 55. Global Sustained Release Injectables Revenue by Type (2015-2020) (Million US$)
Table 56. Global Sustained Release Injectables Revenue Share by Type (2015-2020)
Table 57. Sustained Release Injectables Price by Type 2015-2020 (USD/Unit)
Table 58. Global Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 59. Global Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 60. Global Sustained Release Injectables Consumption Share by Application (2015-2020)
Table 61. AstraZeneca Corporation Information
Table 62. AstraZeneca Description and Major Businesses
Table 63. AstraZeneca Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. AstraZeneca Product
Table 65. AstraZeneca Recent Development
Table 66. Eli Lilly Corporation Information
Table 67. Eli Lilly Description and Major Businesses
Table 68. Eli Lilly Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Eli Lilly Product
Table 70. Eli Lilly Recent Development
Table 71. Sanofi Corporation Information
Table 72. Sanofi Description and Major Businesses
Table 73. Sanofi Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Sanofi Product
Table 75. Sanofi Recent Development
Table 76. Roche Corporation Information
Table 77. Roche Description and Major Businesses
Table 78. Roche Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Roche Product
Table 80. Roche Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Aurobindo Corporation Information
Table 87. Aurobindo Description and Major Businesses
Table 88. Aurobindo Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Aurobindo Product
Table 90. Aurobindo Recent Development
Table 91. Avadel Corporation Information
Table 92. Avadel Description and Major Businesses
Table 93. Avadel Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Avadel Product
Table 95. Avadel Recent Development
Table 96. Biomarin Corporation Information
Table 97. Biomarin Description and Major Businesses
Table 98. Biomarin Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Biomarin Product
Table 100. Biomarin Recent Development
Table 101. Camurus Corporation Information
Table 102. Camurus Description and Major Businesses
Table 103. Camurus Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Camurus Product
Table 105. Camurus Recent Development
Table 106. Critical Pharmaceuticals Corporation Information
Table 107. Critical Pharmaceuticals Description and Major Businesses
Table 108. Critical Pharmaceuticals Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Critical Pharmaceuticals Product
Table 110. Critical Pharmaceuticals Recent Development
Table 111. Alkermes Corporation Information
Table 112. Alkermes Description and Major Businesses
Table 113. Alkermes Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Alkermes Product
Table 115. Alkermes Recent Development
Table 116. Amylin Corporation Information
Table 117. Amylin Description and Major Businesses
Table 118. Amylin Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Amylin Product
Table 120. Amylin Recent Development
Table 121. Ascendis Pharma Corporation Information
Table 122. Ascendis Pharma Description and Major Businesses
Table 123. Ascendis Pharma Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Ascendis Pharma Product
Table 125. Ascendis Pharma Recent Development
Table 126. Taiwan Liposome Company Corporation Information
Table 127. Taiwan Liposome Company Description and Major Businesses
Table 128. Taiwan Liposome Company Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Taiwan Liposome Company Product
Table 130. Taiwan Liposome Company Recent Development
Table 131. Global Sustained Release Injectables Revenue Forecast by Region (2021-2026) (Million US$)
Table 132. Global Sustained Release Injectables Production Forecast by Regions (2021-2026) (K Units)
Table 133. Global Sustained Release Injectables Production Forecast by Type (2021-2026) (K Units)
Table 134. Global Sustained Release Injectables Revenue Forecast by Type (2021-2026) (Million US$)
Table 135. North America Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Europe Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 137. Asia Pacific Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 138. Latin America Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 139. Middle East and Africa Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 140. Sustained Release Injectables Distributors List
Table 141. Sustained Release Injectables Customers List
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Sustained Release Injectables Key Market Segments in This Study
Table 2. Ranking of Global Top Sustained Release Injectables Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sustained Release Injectables Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Naltrexone
Table 5. Major Manufacturers of Exenatide
Table 6. Major Manufacturers of Estradiol
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Sustained Release Injectables Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sustained Release Injectables Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
Table 13. Global Sustained Release Injectables Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Sustained Release Injectables Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2019)
Table 17. Sustained Release Injectables Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Sustained Release Injectables Product Offered
Table 19. Date of Manufacturers Enter into Sustained Release Injectables Market
Table 20. Key Trends for Sustained Release Injectables Markets & Products
Table 21. Main Points Interviewed from Key Sustained Release Injectables Players
Table 22. Global Sustained Release Injectables Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Sustained Release Injectables Production Share by Manufacturers (2015-2020)
Table 24. Sustained Release Injectables Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Sustained Release Injectables Revenue Share by Manufacturers (2015-2020)
Table 26. Sustained Release Injectables Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sustained Release Injectables Production by Regions (2015-2020) (K Units)
Table 29. Global Sustained Release Injectables Production Market Share by Regions (2015-2020)
Table 30. Global Sustained Release Injectables Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Sustained Release Injectables Revenue Market Share by Regions (2015-2020)
Table 32. Key Sustained Release Injectables Players in North America
Table 33. Import & Export of Sustained Release Injectables in North America (K Units)
Table 34. Key Sustained Release Injectables Players in Europe
Table 35. Import & Export of Sustained Release Injectables in Europe (K Units)
Table 36. Key Sustained Release Injectables Players in China
Table 37. Import & Export of Sustained Release Injectables in China (K Units)
Table 38. Key Sustained Release Injectables Players in Japan
Table 39. Import & Export of Sustained Release Injectables in Japan (K Units)
Table 40. Global Sustained Release Injectables Consumption by Regions (2015-2020) (K Units)
Table 41. Global Sustained Release Injectables Consumption Market Share by Regions (2015-2020)
Table 42. North America Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 43. North America Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 45. Europe Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Sustained Release Injectables Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Sustained Release Injectables Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 53. Global Sustained Release Injectables Production by Type (2015-2020) (K Units)
Table 54. Global Sustained Release Injectables Production Share by Type (2015-2020)
Table 55. Global Sustained Release Injectables Revenue by Type (2015-2020) (Million US$)
Table 56. Global Sustained Release Injectables Revenue Share by Type (2015-2020)
Table 57. Sustained Release Injectables Price by Type 2015-2020 (USD/Unit)
Table 58. Global Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 59. Global Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 60. Global Sustained Release Injectables Consumption Share by Application (2015-2020)
Table 61. AstraZeneca Corporation Information
Table 62. AstraZeneca Description and Major Businesses
Table 63. AstraZeneca Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. AstraZeneca Product
Table 65. AstraZeneca Recent Development
Table 66. Eli Lilly Corporation Information
Table 67. Eli Lilly Description and Major Businesses
Table 68. Eli Lilly Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Eli Lilly Product
Table 70. Eli Lilly Recent Development
Table 71. Sanofi Corporation Information
Table 72. Sanofi Description and Major Businesses
Table 73. Sanofi Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Sanofi Product
Table 75. Sanofi Recent Development
Table 76. Roche Corporation Information
Table 77. Roche Description and Major Businesses
Table 78. Roche Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Roche Product
Table 80. Roche Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Aurobindo Corporation Information
Table 87. Aurobindo Description and Major Businesses
Table 88. Aurobindo Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Aurobindo Product
Table 90. Aurobindo Recent Development
Table 91. Avadel Corporation Information
Table 92. Avadel Description and Major Businesses
Table 93. Avadel Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Avadel Product
Table 95. Avadel Recent Development
Table 96. Biomarin Corporation Information
Table 97. Biomarin Description and Major Businesses
Table 98. Biomarin Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Biomarin Product
Table 100. Biomarin Recent Development
Table 101. Camurus Corporation Information
Table 102. Camurus Description and Major Businesses
Table 103. Camurus Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Camurus Product
Table 105. Camurus Recent Development
Table 106. Critical Pharmaceuticals Corporation Information
Table 107. Critical Pharmaceuticals Description and Major Businesses
Table 108. Critical Pharmaceuticals Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Critical Pharmaceuticals Product
Table 110. Critical Pharmaceuticals Recent Development
Table 111. Alkermes Corporation Information
Table 112. Alkermes Description and Major Businesses
Table 113. Alkermes Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Alkermes Product
Table 115. Alkermes Recent Development
Table 116. Amylin Corporation Information
Table 117. Amylin Description and Major Businesses
Table 118. Amylin Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Amylin Product
Table 120. Amylin Recent Development
Table 121. Ascendis Pharma Corporation Information
Table 122. Ascendis Pharma Description and Major Businesses
Table 123. Ascendis Pharma Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Ascendis Pharma Product
Table 125. Ascendis Pharma Recent Development
Table 126. Taiwan Liposome Company Corporation Information
Table 127. Taiwan Liposome Company Description and Major Businesses
Table 128. Taiwan Liposome Company Sustained Release Injectables Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Taiwan Liposome Company Product
Table 130. Taiwan Liposome Company Recent Development
Table 131. Global Sustained Release Injectables Revenue Forecast by Region (2021-2026) (Million US$)
Table 132. Global Sustained Release Injectables Production Forecast by Regions (2021-2026) (K Units)
Table 133. Global Sustained Release Injectables Production Forecast by Type (2021-2026) (K Units)
Table 134. Global Sustained Release Injectables Revenue Forecast by Type (2021-2026) (Million US$)
Table 135. North America Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 136. Europe Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 137. Asia Pacific Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 138. Latin America Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 139. Middle East and Africa Sustained Release Injectables Consumption Forecast by Regions (2021-2026) (K Units)
Table 140. Sustained Release Injectables Distributors List
Table 141. Sustained Release Injectables Customers List
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Sustained Release Injectables Product Picture
Figure 2. Global Sustained Release Injectables Production Market Share by Type in 2020 & 2026
Figure 3. Naltrexone Product Picture
Figure 4. Exenatide Product Picture
Figure 5. Estradiol Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sustained Release Injectables Consumption Market Share by Application in 2020 & 2026
Figure 8. Diabetes
Figure 9. Leukemia
Figure 10. Acromegaly
Figure 11. Other
Figure 12. Sustained Release Injectables Report Years Considered
Figure 13. Global Sustained Release Injectables Revenue 2015-2026 (Million US$)
Figure 14. Global Sustained Release Injectables Production Capacity 2015-2026 (K Units)
Figure 15. Global Sustained Release Injectables Production 2015-2026 (K Units)
Figure 16. Global Sustained Release Injectables Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Sustained Release Injectables Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Sustained Release Injectables Revenue in 2019
Figure 20. Global Sustained Release Injectables Production Market Share by Region (2015-2020)
Figure 21. Sustained Release Injectables Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Sustained Release Injectables Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Sustained Release Injectables Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Sustained Release Injectables Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Sustained Release Injectables Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Sustained Release Injectables Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Sustained Release Injectables Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Sustained Release Injectables Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Figure 30. North America Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 32. North America Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 33. U.S. Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 37. Europe Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 38. Germany Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Sustained Release Injectables Consumption Market Share by Regions in 2019
Figure 46. China Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 58. Latin America Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 59. Latin America Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 60. Mexico Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 66. Turkey Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. U.A.E Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Sustained Release Injectables Production Market Share by Type (2015-2020)
Figure 70. Global Sustained Release Injectables Production Market Share by Type in 2019
Figure 71. Global Sustained Release Injectables Revenue Market Share by Type (2015-2020)
Figure 72. Global Sustained Release Injectables Revenue Market Share by Type in 2019
Figure 73. Global Sustained Release Injectables Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Sustained Release Injectables Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Sustained Release Injectables Market Share by Price Range (2015-2020)
Figure 76. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Figure 77. Global Sustained Release Injectables Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Sustained Release Injectables Consumption Market Share Forecast by Application (2021-2026)
Figure 79. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Avadel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Biomarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Critical Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Amylin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ascendis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Taiwan Liposome Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Global Sustained Release Injectables Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 94. Global Sustained Release Injectables Revenue Market Share Forecast by Regions ((2021-2026))
Figure 95. Global Sustained Release Injectables Production Forecast by Regions (2021-2026) (K Units)
Figure 96. North America Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 97. North America Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Europe Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 99. Europe Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 100. China Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 101. China Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Japan Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 103. Japan Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 104. Global Sustained Release Injectables Consumption Market Share Forecast by Region (2021-2026)
Figure 105. Sustained Release Injectables Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
Figure 1. Sustained Release Injectables Product Picture
Figure 2. Global Sustained Release Injectables Production Market Share by Type in 2020 & 2026
Figure 3. Naltrexone Product Picture
Figure 4. Exenatide Product Picture
Figure 5. Estradiol Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sustained Release Injectables Consumption Market Share by Application in 2020 & 2026
Figure 8. Diabetes
Figure 9. Leukemia
Figure 10. Acromegaly
Figure 11. Other
Figure 12. Sustained Release Injectables Report Years Considered
Figure 13. Global Sustained Release Injectables Revenue 2015-2026 (Million US$)
Figure 14. Global Sustained Release Injectables Production Capacity 2015-2026 (K Units)
Figure 15. Global Sustained Release Injectables Production 2015-2026 (K Units)
Figure 16. Global Sustained Release Injectables Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Sustained Release Injectables Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Sustained Release Injectables Revenue in 2019
Figure 20. Global Sustained Release Injectables Production Market Share by Region (2015-2020)
Figure 21. Sustained Release Injectables Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Sustained Release Injectables Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Sustained Release Injectables Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Sustained Release Injectables Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Sustained Release Injectables Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Sustained Release Injectables Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Sustained Release Injectables Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Sustained Release Injectables Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Figure 30. North America Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 32. North America Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 33. U.S. Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 37. Europe Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 38. Germany Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Sustained Release Injectables Consumption Market Share by Regions in 2019
Figure 46. China Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 58. Latin America Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 59. Latin America Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 60. Mexico Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Sustained Release Injectables Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 66. Turkey Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. U.A.E Sustained Release Injectables Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Sustained Release Injectables Production Market Share by Type (2015-2020)
Figure 70. Global Sustained Release Injectables Production Market Share by Type in 2019
Figure 71. Global Sustained Release Injectables Revenue Market Share by Type (2015-2020)
Figure 72. Global Sustained Release Injectables Revenue Market Share by Type in 2019
Figure 73. Global Sustained Release Injectables Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Sustained Release Injectables Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Sustained Release Injectables Market Share by Price Range (2015-2020)
Figure 76. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Figure 77. Global Sustained Release Injectables Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Sustained Release Injectables Consumption Market Share Forecast by Application (2021-2026)
Figure 79. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Avadel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Biomarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Critical Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Amylin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ascendis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Taiwan Liposome Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Global Sustained Release Injectables Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 94. Global Sustained Release Injectables Revenue Market Share Forecast by Regions ((2021-2026))
Figure 95. Global Sustained Release Injectables Production Forecast by Regions (2021-2026) (K Units)
Figure 96. North America Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 97. North America Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Europe Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 99. Europe Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 100. China Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 101. China Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Japan Sustained Release Injectables Production Forecast (2021-2026) (K Units)
Figure 103. Japan Sustained Release Injectables Revenue Forecast (2021-2026) (US$ Million)
Figure 104. Global Sustained Release Injectables Consumption Market Share Forecast by Region (2021-2026)
Figure 105. Sustained Release Injectables Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
